Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

HIF stabilization inhibits renal epithelial cell migration and is associated with cytoskeletal alterations.

Müller S, Djudjaj S, Lange J, Iacovescu M, Goppelt-Struebe M, Boor P.

Sci Rep. 2018 Jun 22;8(1):9497. doi: 10.1038/s41598-018-27918-9.

2.

Cellular and molecular mechanisms of kidney fibrosis.

Djudjaj S, Boor P.

Mol Aspects Med. 2018 Jun 22. pii: S0098-2997(18)30040-2. doi: 10.1016/j.mam.2018.06.002. [Epub ahead of print] Review.

PMID:
29909119
3.

The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery.

Stoppe C, Averdunk L, Goetzenich A, Soppert J, Marlier A, Kraemer S, Vieten J, Coburn M, Kowark A, Kim BS, Marx G, Rex S, Ochi A, Leng L, Moeckel G, Linkermann A, El Bounkari O, Zarbock A, Bernhagen J, Djudjaj S, Bucala R, Boor P.

Sci Transl Med. 2018 May 16;10(441). pii: eaan4886. doi: 10.1126/scitranslmed.aan4886.

PMID:
29769287
4.

Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.

Djudjaj S, Martin IV, Buhl EM, Nothofer NJ, Leng L, Piecychna M, Floege J, Bernhagen J, Bucala R, Boor P.

J Am Soc Nephrol. 2017 Dec;28(12):3590-3604. doi: 10.1681/ASN.2017020190. Epub 2017 Aug 11.

5.

YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation.

Wang J, Djudjaj S, Gibbert L, Lennartz V, Breitkopf DM, Rauen T, Hermert D, Martin IV, Boor P, Braun GS, Floege J, Ostendorf T, Raffetseder U.

J Cell Mol Med. 2017 Dec;21(12):3494-3505. doi: 10.1111/jcmm.13260. Epub 2017 Jun 30.

6.

Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis.

Heier EC, Meier A, Julich-Haertel H, Djudjaj S, Rau M, Tschernig T, Geier A, Boor P, Lammert F, Lukacs-Kornek V.

J Hepatol. 2017 Jun;66(6):1241-1250. doi: 10.1016/j.jhep.2017.01.008. Epub 2017 Jan 18.

PMID:
28108233
7.

Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries.

Bábíčková J, Klinkhammer BM, Buhl EM, Djudjaj S, Hoss M, Heymann F, Tacke F, Floege J, Becker JU, Boor P.

Kidney Int. 2017 Jan;91(1):70-85. doi: 10.1016/j.kint.2016.07.038. Epub 2016 Sep 24.

PMID:
27678159
8.

Therapeutic nuclear shuttling of YB-1 reduces renal damage and fibrosis.

Wang J, Gibbert L, Djudjaj S, Alidousty C, Rauen T, Kunter U, Rembiak A, Enders D, Jankowski V, Braun GS, Floege J, Ostendorf T, Raffetseder U.

Kidney Int. 2016 Dec;90(6):1226-1237. doi: 10.1016/j.kint.2016.07.008. Epub 2016 Aug 31.

PMID:
27591085
9.

Keratins are novel markers of renal epithelial cell injury.

Djudjaj S, Papasotiriou M, Bülow RD, Wagnerova A, Lindenmeyer MT, Cohen CD, Strnad P, Goumenos DS, Floege J, Boor P.

Kidney Int. 2016 Apr;89(4):792-808. doi: 10.1016/j.kint.2015.10.015. Epub 2016 Feb 6.

PMID:
26924053
10.

The role of PDGF-D in healthy and fibrotic kidneys.

Buhl EM, Djudjaj S, Babickova J, Klinkhammer BM, Folestad E, Borkham-Kamphorst E, Weiskirchen R, Hudkins K, Alpers CE, Eriksson U, Floege J, Boor P.

Kidney Int. 2016 Apr;89(4):848-61. doi: 10.1016/j.kint.2015.12.037. Epub 2016 Feb 18.

PMID:
26924050
11.

Macrophage Migration Inhibitory Factor Mediates Proliferative GN via CD74.

Djudjaj S, Lue H, Rong S, Papasotiriou M, Klinkhammer BM, Zok S, Klaener O, Braun GS, Lindenmeyer MT, Cohen CD, Bucala R, Tittel AP, Kurts C, Moeller MJ, Floege J, Ostendorf T, Bernhagen J, Boor P.

J Am Soc Nephrol. 2016 Jun;27(6):1650-64. doi: 10.1681/ASN.2015020149. Epub 2015 Oct 9.

12.

Anti-interleukin-6 therapy through application of a monogenic protein inhibitor via gene delivery.

Görtz D, Braun GS, Maruta Y, Djudjaj S, van Roeyen CR, Martin IV, Küster A, Schmitz-Van de Leur H, Scheller J, Ostendorf T, Floege J, Müller-Newen G.

Sci Rep. 2015 Oct 1;5:14685. doi: 10.1038/srep14685.

13.

Role of platelet-derived growth factor-CC in capillary rarefaction in renal fibrosis.

Boor P, Bábíčková J, Steegh F, Hautvast P, Martin IV, Djudjaj S, Nakagawa T, Ehling J, Gremse F, Bücher E, Eriksson U, van Roeyen CR, Eitner F, Lammers T, Floege J, Peutz-Kootstra CJ, Ostendorf T.

Am J Pathol. 2015 Aug;185(8):2132-42. doi: 10.1016/j.ajpath.2015.04.022.

PMID:
26216283
14.

Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activities.

van Roeyen CR, Scurt FG, Brandt S, Kuhl VA, Martinkus S, Djudjaj S, Raffetseder U, Royer HD, Stefanidis I, Dunn SE, Dooley S, Weng H, Fischer T, Lindquist JA, Mertens PR.

Cell Commun Signal. 2013 Aug 27;11:63. doi: 10.1186/1478-811X-11-63.

15.

YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo.

Hanssen L, Alidousty C, Djudjaj S, Frye BC, Rauen T, Boor P, Mertens PR, van Roeyen CR, Tacke F, Heymann F, Tittel AP, Koch A, Floege J, Ostendorf T, Raffetseder U.

J Immunol. 2013 Sep 1;191(5):2604-13. doi: 10.4049/jimmunol.1300416. Epub 2013 Jul 19.

16.

Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury.

Djudjaj S, Chatziantoniou C, Raffetseder U, Guerrot D, Dussaule JC, Boor P, Kerroch M, Hanssen L, Brandt S, Dittrich A, Ostendorf T, Floege J, Zhu C, Lindenmeyer M, Cohen CD, Mertens PR.

J Pathol. 2012 Nov;228(3):286-99. doi: 10.1002/path.4076. Epub 2012 Sep 7.

PMID:
22806125
17.

Cold shock Y-box protein-1 participates in signaling circuits with auto-regulatory activities.

Brandt S, Raffetseder U, Djudjaj S, Schreiter A, Kadereit B, Michele M, Pabst M, Zhu C, Mertens PR.

Eur J Cell Biol. 2012 Jun-Jul;91(6-7):464-71. doi: 10.1016/j.ejcb.2011.07.002. Epub 2011 Oct 1. Review.

PMID:
21962637
18.

Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney.

Hanssen L, Frye BC, Ostendorf T, Alidousty C, Djudjaj S, Boor P, Rauen T, Floege J, Mertens PR, Raffetseder U.

J Immunol. 2011 Jul 1;187(1):298-308. doi: 10.4049/jimmunol.1100382. Epub 2011 May 23.

19.

Notch3 is essential for regulation of the renal vascular tone.

Boulos N, Helle F, Dussaule JC, Placier S, Milliez P, Djudjaj S, Guerrot D, Joutel A, Ronco P, Boffa JJ, Chatziantoniou C.

Hypertension. 2011 Jun;57(6):1176-82. doi: 10.1161/HYPERTENSIONAHA.111.170746. Epub 2011 Apr 25.

PMID:
21518968
20.

Extracellular YB-1 blockade in experimental nephritis upregulates Notch-3 receptor expression and signaling.

Raffetseder U, Rauen T, Boor P, Ostendorf T, Hanssen L, Floege J, En-Nia A, Djudjaj S, Frye BC, Mertens PR.

Nephron Exp Nephrol. 2011;118(4):e100-8. doi: 10.1159/000324209. Epub 2011 Mar 2.

PMID:
21372592
21.

Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.

Dahl E, En-Nia A, Wiesmann F, Krings R, Djudjaj S, Breuer E, Fuchs T, Wild PJ, Hartmann A, Dunn SE, Mertens PR.

BMC Cancer. 2009 Nov 24;9:410. doi: 10.1186/1471-2407-9-410.

22.

YB-1 acts as a ligand for Notch-3 receptors and modulates receptor activation.

Rauen T, Raffetseder U, Frye BC, Djudjaj S, Mühlenberg PJ, Eitner F, Lendahl U, Bernhagen J, Dooley S, Mertens PR.

J Biol Chem. 2009 Sep 25;284(39):26928-40. doi: 10.1074/jbc.M109.046599. Epub 2009 Jul 29.

23.

Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen.

Frye BC, Halfter S, Djudjaj S, Muehlenberg P, Weber S, Raffetseder U, En-Nia A, Knott H, Baron JM, Dooley S, Bernhagen J, Mertens PR.

EMBO Rep. 2009 Jul;10(7):783-9. doi: 10.1038/embor.2009.81. Epub 2009 May 29.

24.

Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1.

Raffetseder U, Rauen T, Djudjaj S, Kretzler M, En-Nia A, Tacke F, Zimmermann HW, Nelson PJ, Frye BC, Floege J, Stefanidis I, Weber C, Mertens PR.

Kidney Int. 2009 Jan;75(2):185-96. doi: 10.1038/ki.2008.457. Epub 2008 Sep 17.

Supplemental Content

Loading ...
Support Center